Yoshihiro Urade Selected Research

prostaglandin D2 receptor

1/2018	Lipocalin-type prostaglandin D synthase-derived PGD2 attenuates malignant properties of tumor endothelial cells.
8/2014	Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR.
6/2014	Mast cell-derived prostaglandin D2 inhibits colitis and colitis-associated colon cancer in mice.
12/2008	Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo.
8/2006	Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Urade Research Topics

Disease

23	Inflammation (Inflammations) 01/2021 - 03/2004
11	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 11/2006
9	Neoplasms (Cancer) 01/2022 - 02/2007
6	Narcolepsy 01/2021 - 08/2008
6	Pain (Aches) 01/2021 - 08/2002
6	Hypoxia (Hypoxemia) 01/2021 - 04/2007
6	Body Weight (Weight, Body) 01/2019 - 01/2004
6	Insulin Resistance 01/2019 - 04/2011
6	Hypersensitivity (Allergy) 07/2011 - 01/2002
5	Infections 01/2021 - 07/2011
5	Pneumonia (Pneumonitis) 01/2016 - 01/2002
5	Globoid Cell Leukodystrophy (Krabbe Disease) 06/2007 - 06/2002
4	Obesity 01/2019 - 04/2011
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2013 - 10/2002
4	Atherosclerosis 01/2009 - 08/2005
3	Asthma (Bronchial Asthma) 09/2021 - 01/2002
3	Fibrosis (Cirrhosis) 11/2020 - 04/2011
3	Seizures (Absence Seizure) 11/2018 - 03/2014
3	Alzheimer Disease (Alzheimer's Disease) 04/2014 - 04/2007
3	Ischemia 01/2014 - 04/2007
3	Diabetic Nephropathies (Diabetic Nephropathy) 11/2012 - 09/2002
3	Necrosis 11/2011 - 10/2002
3	Pathologic Processes 02/2009 - 12/2002
3	Atherosclerotic Plaque (Atheroma) 01/2009 - 08/2007
3	Demyelinating Diseases (Demyelinating Disease) 04/2006 - 06/2002
2	Nasal Polyps (Nasal Polyp) 09/2021 - 07/2007
2	Rhinosinusitis 09/2021 - 01/2009
2	Hyperplasia 09/2021 - 07/2015
2	Acute Retinal Necrosis Syndrome 01/2021 - 01/2020
2	Cataplexy 01/2021 - 01/2018
2	Carcinogenesis 11/2020 - 06/2014
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2018 - 09/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2006
2	Nervous System Diseases (Neurological Disorders) 01/2018 - 06/2007
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 06/2006
2	African Trypanosomiasis (Nagana) 09/2017 - 12/2002
2	Hyperalgesia 10/2014 - 02/2011
2	Neuralgia (Stump Neuralgia) 10/2014 - 02/2011
2	Adenoma (Adenomas) 08/2014 - 02/2007
2	Colonic Neoplasms (Colon Cancer) 06/2014 - 02/2007
2	Colitis 06/2014 - 03/2011
2	Normal Pressure Hydrocephalus 04/2014 - 12/2003
2	Reperfusion Injury 01/2014 - 06/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 06/2007
2	Wasting Syndrome (Wasting Disease) 08/2013 - 05/2009
2	Glucose Intolerance 02/2013 - 08/2005
2	Multiple Sclerosis 01/2013 - 06/2007
2	Mental Disorders (Mental Disorder) 10/2012 - 08/2005
2	Contact Dermatitis (Eczema, Contact) 07/2011 - 08/2006
2	Infarction (Infarctions) 06/2009 - 04/2007

Drug/Important Bio-Agent (IBA)

48	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2022 - 01/2002
40	Prostaglandin D2IBA 09/2021 - 04/2003
34	LipocalinsIBA 01/2021 - 01/2002
33	ProstaglandinsIBA 01/2021 - 06/2002
17	Prostaglandins DIBA 01/2014 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
8	Messenger RNA (mRNA)IBA 11/2020 - 04/2005
8	EnzymesIBA 11/2018 - 06/2006
6	Dinoprostone (PGE2)FDA Link 07/2015 - 06/2006
6	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 08/2005
5	CytokinesIBA 01/2020 - 01/2002
5	prostaglandin D2 receptorIBA 01/2018 - 08/2006
5	LipidsIBA 01/2017 - 01/2002
5	Prostaglandin H2 (PGH(2))IBA 06/2011 - 12/2002
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2008
4	OrexinsIBA 01/2021 - 11/2009
4	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 04/2014
4	Prostaglandins EIBA 02/2011 - 06/2006
3	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2020 - 09/2009
3	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 08/2009
3	Pentylenetetrazole (Metrazol)IBA 11/2018 - 03/2014
3	AntigensIBA 07/2015 - 06/2006
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 06/2006
3	Prostaglandins FIBA 03/2009 - 12/2002
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 11/2012
2	SteroidsIBA 09/2021 - 10/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2021 - 02/2007
2	AntioxidantsIBA 01/2021 - 04/2011
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 08/2006
2	Long Noncoding RNAIBA 01/2021 - 11/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 06/2009
2	AdiponectinIBA 01/2019 - 12/2012
2	CholesterolIBA 01/2019 - 02/2013
2	Amyloid beta-PeptidesIBA 04/2014 - 04/2007
2	AcidsIBA 01/2014 - 03/2013
2	GlucocorticoidsIBA 01/2014 - 06/2009
2	11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acidIBA 08/2013 - 12/2011
2	DystrophinIBA 08/2013 - 05/2009
2	Interleukin-13IBA 03/2013 - 11/2012
2	Insulin (Novolin)FDA Link 12/2012 - 04/2011
2	Small Interfering RNA (siRNA)IBA 06/2012 - 07/2011
2	Prostaglandin-E SynthasesIBA 02/2011 - 06/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2011 - 06/2006
2	Dopamine (Intropin)FDA LinkGeneric 03/2010 - 11/2009

Therapy/Procedure

8	Therapeutics 09/2021 - 04/2005
2	Kampo Medicine (Kampo) 01/2021 - 06/2014
2	Oral Administration 11/2012 - 11/2011
2	Spinal Injections 10/2012 - 02/2011